These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 11820628)

  • 1. Mutagenesis, apoptosis, basic relation to carcinogenic models.
    Voutsinas G
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():56-7. PubMed ID: 11820628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
    Tubiana M
    Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations and DNA repair in human carcinogenesis.
    Dixon K; Kopras E
    Semin Cancer Biol; 2004 Dec; 14(6):441-8. PubMed ID: 15489137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genotype of the human cancer cell: implications for risk analysis.
    Williams JR; Russell J; Dicello JF; Mabry MH
    Mutat Res; 1996 Sep; 365(1-3):17-42. PubMed ID: 8898987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Generalities about carcinogenesis].
    Tubiana M
    C R Biol; 2008 Feb; 331(2):114-25. PubMed ID: 18241804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cadmium carcinogenesis.
    Joseph P
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):272-9. PubMed ID: 19371617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
    Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
    Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dietary mutagens in cancer and atherosclerosis.
    Ferguson LR
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):343-9. PubMed ID: 19474716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental carcinogens and mutational pathways in atherosclerosis.
    Pulliero A; Godschalk R; Andreassi MG; Curfs D; Van Schooten FJ; Izzotti A
    Int J Hyg Environ Health; 2015 May; 218(3):293-312. PubMed ID: 25704189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of DNA damage signaling genes in benzidine-treated HepG2 cells.
    Ching Chen S; Hseu YC; Sung JC; Chen CH; Chen LC; Chung KT
    Environ Mol Mutagen; 2011 Oct; 52(8):664-72. PubMed ID: 21818781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Theory and practice of primary cancer prevention].
    Tompa A
    Magy Onkol; 2007; 51(1):7-21. PubMed ID: 17417671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations and altered expression of the human cancer genes: what they tell us about causes.
    Devereux TR; Risinger JI; Barrett JC
    IARC Sci Publ; 1999; (146):19-42. PubMed ID: 10353382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of human cancer: biomarkers of genotoxic exposure and susceptibility.
    Grant SG
    J Environ Pathol Toxicol Oncol; 2001; 20(4):245-61. PubMed ID: 11797834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.
    Bignold LP
    Carcinogenesis; 2004 Mar; 25(3):299-307. PubMed ID: 14604890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.
    De Flora S; Izzotti A; Randerath K; Randerath E; Bartsch H; Nair J; Balansky R; van Schooten F; Degan P; Fronza G; Walsh D; Lewtas J
    Mutat Res; 1996 Dec; 366(3):197-238. PubMed ID: 9033668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal changes in cancer in relation to exposure to carcinogenic agents.
    Mitelman F
    IARC Sci Publ; 1984; (59):351-60. PubMed ID: 6545286
    [No Abstract]   [Full Text] [Related]  

  • 19. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
    Ye Y; Xiao Y; Wang W; Wang Q; Yearsley K; Wani AA; Yan Q; Gao JX; Shetuni BS; Barsky SH
    Mol Cancer Res; 2009 Dec; 7(12):1984-99. PubMed ID: 19996304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.